Massive Bio Tech Stack

AI platform matching cancer patients to clinical trials across 17 countries

Hospitals and Health Care Istanbul 51–200 employees Founded 2014 Privately Held

Massive Bio operates a patient-matching platform for oncology trials, built on Python, PHP, and modern cloud infrastructure (AWS, Azure, Kubernetes), with emerging LLM integration (OpenAI, Anthropic, LangChain, LlamaIndex). The hiring mix—dominated by sales (59 roles) and ops (35), with minimal engineering (5)—reveals a go-to-market and operations-driven organization scaling trial enrollment velocity rather than product infrastructure. Pain points center on reducing enrollment friction and balancing growth with delivery capacity, suggesting they're hitting scaling limits in their current playbook.

Tech Stack 34 technologies

Core StackPython PHP AWS Docker Kubernetes Gusto Laravel TypeScript MySQL JavaScript jQuery Jira WordPress OpenAI Anthropic LangChain PostgreSQL FastAPI JazzHR Microsoft Office DUO SQL Azure Git Deel CSS HTML PHPUnit Azure OpenAI LlamaIndex+4 more

What Massive Bio Is Building

◆Challenges

Reducing friction in clinical trial enrollment
Increasing throughput without headcount growth
Institutional adoption
Reducing cycle time
Balancing growth and delivery capacity
Eliminating enrollment friction
Geographic enrollment barriers
Expanding physician network
Clinical trial patient referral growth
Removing enrollment friction

▲Active Projects

Referral physician network
Standardize scalable enrollment playbooks across regions
Delivery capacity expansion
Model capacity constraints
Event pipeline development
Build dashboards tracking funnel performance
Pilot definition
Physician roundtables across europe
Patient connect
Ctms

Hiring Activity

Steady120 roles · 50 in 30d

Department

Sales

Ops

Product

Support

Engineering

Marketing

Operations

Data

Seniority

Senior

Mid

Manager

Lead

Junior

Director

Intern

Company intelligence

Find more companies like Massive Bio by tech stack, pain points and active projects

Get started free

About Massive Bio

Massive Bio connects cancer patients to appropriate clinical trials using proprietary AI matching, operating across 17 countries in North America, Europe, and LATAM. The company onboards patients, partners with pharmaceutical companies and CROs, and works with healthcare institutions to accelerate oncology trial enrollment and reduce dropout rates. Founded in 2014 and headquartered in Istanbul, the organization serves 60+ pharma and CRO customers alongside 130+ strategic partners. Active projects include standardizing enrollment playbooks across regions, expanding physician networks in Europe, and building referral mechanisms—all pointing to operational scaling beyond their initial market.

HeadquartersIstanbul

Company Size51–200 employees

Founded2014

Hiring MarketsAustralia, France, Italy, Brazil, Poland, Greece, Israel, Argentina

Frequently Asked Questions

What tech stack does Massive Bio use?

Python, PHP, TypeScript, and JavaScript for development; AWS and Azure for cloud; Kubernetes and Docker for containerization; PostgreSQL and MySQL for databases; OpenAI, Anthropic, and LangChain for LLM features; Laravel and FastAPI for frameworks.

Where does Massive Bio operate geographically?

Active in 17 countries spanning North America, Europe, and Latin America. Currently hiring across 16+ nations including the US, UK, Germany, France, Italy, Brazil, Poland, Argentina, and Australia.